NCT00918866View on ClinicalTrials.gov

A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Pulmonary Heart Disease
Interventions
DRUG

Definity

one bolus dose of Definity per intravenous injection, 30-60 second injection, dose value calculation = maximum of 10 microliter/kg patient weight

Trial Locations (8)

44195

The Cleveland Clinic Foundation, Cleveland

55426

Methodist Hospital, Saint Louis Park

60611

Northwestern Memorial Hospital, Chicago

60637

University of Chicago Medical Center, Chicago

64111

Cardiovascular Consultants, Kansas City

77555

The University of Texas Medical Branch at Galveston, Galveston

97239

Oregon Health and Sciences University, Portland

07666

Holy Name Hospital, Teaneck

Sponsors
All Listed Sponsors
lead

Lantheus Medical Imaging

INDUSTRY

NCT00918866 - A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure | Biotech Hunter | Biotech Hunter